Journal
/
Immunology and Infection
/
Assessing Serum Neutralization Against SARS-CoV-2 with Pseudotyped Viruses…
/
SARS-CoV-2 Pseudotype Virus Production and Serum Neutralization Assay (Video) | JoVE …
JoVE Journal
Immunology and Infection
Immunology and Infection
A subscription to JoVE is required to view this content. Sign in or start your free trial.
SARS-CoV-2 Pseudotype Virus Production and Serum Neutralization Assay (Video) | JoVE
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/200835-v
•
04:50 min
•
November 21st, 2023
SARS-CoV-2 Pseudotype Virus Production and Serum Neutralization Assay (Video) | JoVE
Assessing Serum Neutralization Against SARS-CoV-2 with Pseudotyped Viruses
November 21st, 2023
•
Tobia Fantoni*1, Michele Bissoli*1, Chiara Stefani1, Mauro Voi1, Alexandrina Dabija1, Rebecca Casula1, Domenico Luca Minafra1, Julys da Fonseca Palmeira2, Enrique Roberto Argañaraz2, Martin Mayora-Neto3, Nigel J. Temperton3, Donato Zipeto1, Alessandra Ruggiero1
1Department of Neuroscience, Biomedicine and Movement, University of Verona, 2Laboratory of Molecular Neurovirology, Faculty of Health Science, University of Brasília, 3Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent and Greenwich at Medway
* These authors contributed equally